Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BLRX will decline by -2.12% over the next 2 Weeks and hit $2.82 by Monday, January 5, 2026. In that time frame, BLRX's share price is expected to range between $2.70 and $2.94.
BearishAverageBullishBLRX shares rose +4.17% in Tuesday, December 23, 2025's trading session, rising from a previous close of $2.88 to move at $3.00. The stock demonstrated notable intraday movement (see BLRX's key stats for a full breakdown), fluctuating between $2.83 and $3.00, a +6.01% trading range. While recent weeks have seen some volatility, BLRX has managed to secure a -9.64% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 21.81K shares changing hands, 1.61K more than the previous session. This amounted to $65.43K in total market activity.
Will BLRX Continue Its Downward Trend?
According to analyst ratings and projections for BLRX, BioLineRx Ltd. shares are anticipated to decrease by -2.16%, potentially reaching $2.94 per share by January 5, 2026. Short-term technical indicators currently suggest a neutral sentiment for BLRX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the BLRX stock forecast, now is not the best time to buy BLRX stock because its current trading price is +6.42% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on BLRX covering social and institutional perspectives.
BLRX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BLRX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 40.68% to 41.79%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 44.26%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 43.94%, maintains a neutral outlook for the long term. Insights into BLRX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
BioLineRx Short-Term Forecasts
BLRX Forecast For Next 5 Days
Our algorithm anticipates BioLineRx (BLRX) stock could hit $2.73 by Dec 30, 2025. This represents a -8.97% fall from today's price, following a -12.99% change over the past five days.
BLRX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for BioLineRx Ltd. (BLRX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $2.70, which would mean a -10.00% decrease from the current price of $3.00. Projections for this period range from a high of $3.14 to a low of $2.23.
BLRX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for BioLineRx's price over the next three months point to a drop. BLRX stock is expected to peak at $4.86 on Dec 30, 2025 before potentially dipping to $0.16 on Feb 13, 2026. On average, BLRX is likely to trade around $2.47 in the coming 90 days.
BioLineRx Stock Forecast 2025
Based on our predictive models, BioLineRx (BLRX) is expected to trade between $2.21 and $4.86 throughout 2025. This would result in an average price of $3.60, potentially offering investors a +20.00% return from current levels.
BioLineRx Ltd. Monthly Forecast 2025–2026
December 2025
According to our latest forecast models, BioLineRx Ltd. (BLRX) is positioned to show a strong performance in December 2025. The price is predicted to move between $2.21 and $4.86, settling at an average of $3.60. This could translate to a +20.00% gain.
January 2026
Based on current market signals, BioLineRx Ltd. is projected to trend january 2026. We forecast a trading range from $0.90 to $4.67, with a likely average price of $2.82. Investors could expect a potential return of -6.00%.
February 2026
Our predictive algorithms indicate BioLineRx Ltd. stock may see a shift in February 2026. The expected range spans $0.16–$3.12, with an average target of $1.70. This represents a cautious outlook and a possible loss of -43.33%.
March 2026
Analyzing established trends, BioLineRx Ltd. looks set to move in March 2026. Projections place the stock between $0.83 and $3.83, averaging around $2.50. This suggests a -16.67% loss from current levels.
April 2026
Market indicators suggest BioLineRx Ltd. could experience notable changes during April 2026. Prices could fluctuate within $0.00 to $3.57, with a midpoint forecast of $1.70. The stock might deliver a -43.33% loss.
May 2026
Forecasting for May 2026, models estimate that BioLineRx Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $3.09, averaging $1.96. This signals a cautious trajectory with potential returns around -34.67%.
June 2026
According to our latest forecast models, BioLineRx Ltd. (BLRX) is positioned to show a strong performance in June 2026. The price is predicted to move between $0.00 and $2.92, settling at an average of $2.19. This could translate to a -27.00% loss.
July 2026
Based on current market signals, BioLineRx Ltd. is projected to trend july 2026. We forecast a trading range from $0.00 to $1.90, with a likely average price of $1.83. Investors could expect a potential return of -39.00%.
August 2026
Our predictive algorithms indicate BioLineRx Ltd. stock may see a shift in August 2026. The expected range spans $0.00–$0.76, with an average target of $2.27. This represents a cautious outlook and a possible loss of -24.33%.
September 2026
Analyzing established trends, BioLineRx Ltd. looks set to move in September 2026. Projections place the stock between $0.00 and $0.00, averaging around $2.15. This suggests a -28.33% loss from current levels.
October 2026
Market indicators suggest BioLineRx Ltd. could experience notable changes during October 2026. Prices could fluctuate within $0.00 to $0.00, with a midpoint forecast of $1.91. The stock might deliver a -36.33% loss.
November 2026
Forecasting for November 2026, models estimate that BioLineRx Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $1.57. This signals a cautious trajectory with potential returns around -47.67%.
December 2026
According to our latest forecast models, BioLineRx Ltd. (BLRX) is positioned to show a strong performance in December 2026. The price is predicted to move between $0.00 and $0.00, settling at an average of $1.20. This could translate to a -60.00% loss.
BLRX's history of dividends and stock splits also plays a role in long-term investor confidence.

